Patents by Inventor Paul G. Krause

Paul G. Krause has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9814886
    Abstract: In some examples, an electromechanical disassociation state (EMD) of a heart of a patient can be treated by delivering electrical stimulation to a tissue site to at least one of modulate afferent nerve activity or inhibit efferent nerve activity upon determining that the heart is in an electromechanical dissociation state, where the tissue site comprises at least one of a nonmyocardial tissue site or a nonvascular cardiac tissue site. The delivery of electrical stimulation may effectively treat the EMD state of the heart, e.g., by enabling effective mechanical contraction of the heart. In another example, an electromechanical disassociation state of a heart of a patient can be treated by determining autonomic nervous system activity associated with a detected EMD state of the heart of a patient, and delivering electrical stimulation therapy to the patient based on the determined autonomic nervous system activity of the patient associated with the EMD state.
    Type: Grant
    Filed: January 29, 2010
    Date of Patent: November 14, 2017
    Assignee: Medtronic, Inc.
    Inventors: Xiaohong Zhou, Paul G. Krause, William T. Donofrio
  • Patent number: 9775987
    Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: October 3, 2017
    Assignee: Medtronic, Inc.
    Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, James D. Reinke, Timothy Davis
  • Patent number: 9744364
    Abstract: A system including a programmable implantable monitoring device and a programmer for programming the device and a method of use thereof. The programmer may be configured to transmit programming commands responsive to entry of a reason for monitoring to the implantable device including a prioritization of an arrhythmia storage criterion. The implantable may be configured to thereafter store and/or transmit records of the arrhythmia according to the prioritization. The programmer may be configured to transmit the patient's age to the implantable device and the implantable may be configured to thereafter apply arrhythmia detection criteria based upon the patient's age.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: August 29, 2017
    Assignee: Medtronic, Inc.
    Inventors: Charles R Gordon, Paul G Krause, Grant Alan Neitzell, Shantanu Sarkar, Ryan Wyszynski
  • Patent number: 9597505
    Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: March 21, 2017
    Assignee: Medtronic, Inc.
    Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Xiaohong Zhou, Gerald P. Arne, David J. Peichel, James D. Reinke
  • Patent number: 9289613
    Abstract: An electrical parameter value indicative of an impedance of an electrical path between a first medical device implanted within a patient and a second medical device implanted within the patient may be determined by generating and delivering an electrical signal between electrodes connected to the first medical device and sensing the electrical signal with two or more sense electrodes connected to the second medical device. In some examples, the electrical parameter value indicative of the impedance may be used to detect a system integrity issue, such as relative movement between the first and second medical devices, such as between leads connected to the medical devices, or a lead-related condition. In other examples, the determined impedance may indicate a transthoracic impedance of the patient.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: March 22, 2016
    Assignee: Medtronic, Inc.
    Inventors: John E. Burnes, Paul G. Krause
  • Patent number: 9192769
    Abstract: Techniques for minimizing interference between the first and second medical devices or between the different therapy modules of a common medical device are described herein. In some examples, a medical device may include shunt-current mitigation circuitry and/or at least one clamping structure that helps minimize or even eliminate shunt-current that feeds into a first therapy module of the medical device via one or more electrodes electrically connected to the first therapy module. The shunt-current may be generated by the delivery of electrical stimulation by a second therapy module. The second therapy module may be enclosed in a common housing with the first therapy module or may be separate, e.g., a part of a separate medical device.
    Type: Grant
    Filed: August 31, 2009
    Date of Patent: November 24, 2015
    Assignee: Medtronic, Inc.
    Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Gerald P. Arne, Xiaohong Zhou
  • Patent number: 9026206
    Abstract: An implantable medical system that includes a cardiac therapy module and a neurostimulation therapy module may identify when neurostimulation electrodes have migrated toward a patient's heart. In some examples, the system may determine whether the neurostimulation electrodes have migrated toward the patient's heart based on a physiological response to an electrical signal delivered to the patient via the neurostimulation electrodes. In addition, in some examples, the system may determine whether the neurostimulation electrodes have migrated toward the patient's heart based on an electrical cardiac signal sensed via the neurostimulation electrodes.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: May 5, 2015
    Assignee: Medtronic, Inc.
    Inventors: Paul G. Krause, Avram Scheiner
  • Publication number: 20150088216
    Abstract: A system including a programmable implantable monitoring device and a programmer for programming the device and a method of use thereof. The programmer may be configured to transmit programming commands responsive to entry of a reason for monitoring to the implantable device including a prioritization of an arrhythmia storage criterion. The implantable may be configured to thereafter store and/or transmit records of the arrhythmia according to the prioritization. The programmer may be configured to transmit the patient's age to the implantable device and the implantable may be configured to thereafter apply arrhythmia detection criteria based upon the patient's age.
    Type: Application
    Filed: April 9, 2014
    Publication date: March 26, 2015
    Inventors: Charles R Gordon, Paul G Krause, Grant Alan Neitzell, Shantanu Sarkar, Ryan Wyszynski
  • Patent number: 8774918
    Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: July 8, 2014
    Assignee: Medtronic, Inc.
    Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Xiaohong Zhou, Gerald P. Arne, David J. Peichel, James D. Reinke
  • Patent number: 8688210
    Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: April 1, 2014
    Assignee: Medtronic, Inc.
    Inventors: John E. Burnes, Paul G. Krause, William T. Donofrio, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, James D. Reinke
  • Patent number: 8676310
    Abstract: An implantable medical device (IMD) may include a battery dedicated to providing cardiac stimulation therapy and a separate power source that provides power for electrical stimulation therapy. Such a configuration preserves the battery dedicated for providing cardiac stimulation therapy even if the second power source is depleted. As an example, the IMD may comprise a cardiac stimulation module configured to deliver at least one stimulation therapy selected from a group consisting of pacing, cardioversion and defibrillation. The IMD further comprises a electrical stimulation module configured to deliver electrical stimulation therapy, a first power source including a battery, wherein the first power source is configured to supply power to the cardiac stimulation module and not to the electrical stimulation module, and a second power source. The second power source is configured to supply power to at least the electrical stimulation module.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: March 18, 2014
    Assignee: Medtronic, Inc.
    Inventors: John E. Burnes, Paul G. Krause, William T. Donofrio
  • Patent number: 8611996
    Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: December 17, 2013
    Assignee: Medtronic, Inc.
    Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Xiaohong Zhou, Gerald P. Arne, David J. Peichel, James D. Reinke
  • Patent number: 8606355
    Abstract: An implantable medical system is disclosed that is configured to detect a laryngeal activation response of a patient to an electrical stimulation signal. Detection of the laryngeal activation can be used to control vagal stimulation therapy to a patient.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: December 10, 2013
    Assignee: Medtronic, Inc.
    Inventor: Paul G. Krause
  • Patent number: 8578118
    Abstract: An implantable medical device and associated method store physiological data in response to detecting a physiological event. The medical device includes multiple first memory locations allocated to each of a number of physiological event types and a second single memory location allocated for storing entries of physiological signal data corresponding to each of the plurality of physiological event types.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: November 5, 2013
    Assignee: Medtronic, Inc.
    Inventors: Karen J. Kleckner, Paul G. Krause, Traci K. Washburn, Melinda A. Kolstad
  • Patent number: 8560060
    Abstract: The disclosure describes techniques of reducing or eliminating a commonality between two modules within the same implantable medical device. Each module within the implantable medical device provides therapy to a patient. The commonality between the two modules exists due to at least one common component shared by the two modules. The commonality between the two modules may create common-mode interference and a shunt current. In accordance with this disclosure, various isolation circuits located at various locations are disclosed to reduce or eliminate the commonality between the two modules. The reduction or elimination of the commonality between the two modules may reduce or eliminate common-mode interference and the shunt current.
    Type: Grant
    Filed: August 31, 2009
    Date of Patent: October 15, 2013
    Assignee: Medtronic, Inc.
    Inventors: William T. Donofrio, Paul G. Krause, James D. Reinke, David J. Peichel, Gerald P. Arne
  • Patent number: 8532779
    Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: September 10, 2013
    Assignee: Medtronic, Inc.
    Inventors: Paul G. Krause, John E. Burnes, William T. Donofrio, David J. Peichel, Gerald P. Arne, Xiaohong Zhou, James D. Reinke
  • Patent number: 8527045
    Abstract: An implantable medical system that includes a cardiac therapy module and a neurostimulation therapy module may identify when neurostimulation electrodes have migrated toward a patient's heart. In some examples, the system may determine whether the neurostimulation electrodes have migrated toward the patient's heart based on a physiological response to an electrical signal delivered to the patient via the neurostimulation electrodes. In addition, in some examples, the system may determine whether the neurostimulation electrodes have migrated toward the patient's heart based on an electrical cardiac signal sensed via the neurostimulation electrodes.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: September 3, 2013
    Assignee: Medtronic, Inc.
    Inventors: Paul G. Krause, Avram Scheiner
  • Patent number: 8498698
    Abstract: The disclosure describes techniques of reducing or eliminating a commonality between two modules within the same implantable medical device. Each module within the implantable medical device provides therapy to a patient. The commonality between the two modules exists due to at least one common component shared by the two modules. The commonality between the two modules may create common-mode interference and a shunt current. In accordance with this disclosure, various isolation circuits located at various locations are disclosed to reduce or eliminate the commonality between the two modules. The reduction or elimination of the commonality between the two modules may reduce or eliminate common-mode interference and the shunt current.
    Type: Grant
    Filed: August 31, 2009
    Date of Patent: July 30, 2013
    Assignee: Medtronic, Inc.
    Inventors: William T. Donofrio, Paul G. Krause, James D. Reinke, David J. Peichel, Gerald P. Arne
  • Patent number: 8473057
    Abstract: Techniques for minimizing interference between first and second medical devices of a therapy system may include providing an outer housing for at least one of the medical devices that comprises an electrically insulative layer formed over at least the electrically conductive portions (e.g., an electrically conductive layer) of the housing, or providing an electrically insulative pouch around an electrically conductive housing of at least the first medical device. The electrically insulative layer or electrically insulative pouch may reduce or even eliminate shunt-current that flows into the medical device via the housing. The shunt-current may be generated by the delivery of electrical stimulation by the second medical device. In some examples, the techniques may also include shunt-current mitigation circuitry that helps minimize or even eliminate shunt-current that feeds into the first medical device via one or more electrodes electrically connected to the first medical device.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: June 25, 2013
    Assignee: Medtronic, Inc.
    Inventors: William T. Donofrio, William J. Havel, Chris C. Christiansen, Paul G. Krause
  • Patent number: 8452394
    Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: May 28, 2013
    Assignee: Medtronic, Inc.
    Inventors: John E. Burnes, Paul G. Krause, William T. Donofrio, James D. Reinke, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, Timothy Davis